ConductScience.org, home

Paper41533907

Levodopa Suppresses Choroidal Neovascularization Through a Tyrosinase-Dependent Dual Mechanism.

Veernala I and 5 others. Invest Ophthalmol Vis Sci, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Levodopa Suppresses Choroidal Neovascularization Through a Tyrosinase-Dependent Dual Mechanism. Papers, record 41533907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41533907

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Levodopa Suppresses Choroidal Neovascularization Through a Tyrosinase-Dependent Dual Mechanism.
PubMed
Journal
Invest Ophthalmol Vis Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-07-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Veernala IInduvahi
2Cuamatzi-Castelan ASAndrea Sara
3Rajesh AAmrita
4Gong JJoyce
5D'Souza GJGodlyn J
6Lavine JAJeremy A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LevodopaMajor topic
Monophenol MonooxygenaseMajor topic
Choroidal NeovascularizationMajor topic
Animals
Mice
Disease Models, Animal
Mice, Inbred C57BL
Mice, Knockout
Receptors, Dopamine D2
Receptors, LDL
Dopamine Agonists
Choroid

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 EY034486NEI NIH HHSUnited StatesR01EY034486PubMedNIH RePORTER
R01 EY036826NEI NIH HHSUnited StatesR01EY036826PubMedNIH RePORTER
P30 CA060553NCI NIH HHSUnited StatesP30CA060553PubMedNIH RePORTER

Download CSV of grants

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125349810Iris color and associated pathological ocular complications: a review of epidemiologic studies.Int J Ophthalmol2014https://conductscience.org/library/papers/25349810PubMed
228906084Updates on the Epidemiology of Age-Related Macular Degeneration.Asia Pac J Ophthalmol (Phila)2017https://conductscience.org/library/papers/28906084PubMed
338965321Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020.Eye (Lond)2024https://conductscience.org/library/papers/38965321PubMed
432437334Retinal microglia are critical for subretinal neovascular formation.JCI Insight2020https://conductscience.org/library/papers/32437334PubMed
537440012Decoding Race and Age-Related Macular Degeneration: GPR 143 Activity Is the Key.Adv Exp Med Biol2023https://conductscience.org/library/papers/37440012PubMed
626974308Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1.Nat Med2016https://conductscience.org/library/papers/26974308PubMed
733187533Ocular macrophage origin and heterogeneity during steady state and experimental choroidal neovascularization.J Neuroinflammation2020https://conductscience.org/library/papers/33187533PubMed
826524704Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration.Am J Med2016https://conductscience.org/library/papers/26524704PubMed
940891775Sustained Benefit of Short-Term Levodopa Treatment on Inner Retinal Function in Patients With Diabetes.Transl Vis Sci Technol2025https://conductscience.org/library/papers/40891775PubMed
1032610682Experimental Models in Neovascular Age Related Macular Degeneration.Int J Mol Sci2020https://conductscience.org/library/papers/32610682PubMed
1123423728The albino mutation of tyrosinase alters ocular angiogenic responsiveness.Angiogenesis2013https://conductscience.org/library/papers/23423728PubMed
1235396574Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis.Eye (Lond)2023https://conductscience.org/library/papers/35396574PubMed
1326260587IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis.Nat Commun2015https://conductscience.org/library/papers/26260587PubMed
1432276449A G-Protein Coupled Receptor and Macular Degeneration.Cells2020https://conductscience.org/library/papers/32276449PubMed
1512972764Mouse model of subretinal neovascularization with choroidal anastomosis.Retina2003https://conductscience.org/library/papers/12972764PubMed
1636821388CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization.JCI Insight2023https://conductscience.org/library/papers/36821388PubMed
1737572663Dopamine signaling from ganglion cells directs layer-specific angiogenesis in the retina.Curr Biol2023https://conductscience.org/library/papers/37572663PubMed
1837146684Levodopa Is Associated with Reduced Development of Neovascular Age-Related Macular Degeneration.Ophthalmol Retina2023https://conductscience.org/library/papers/37146684PubMed
1932051147Novel Detection and Restorative Levodopa Treatment for Preclinical Diabetic Retinopathy.Diabetes2020https://conductscience.org/library/papers/32051147PubMed
2010967078VEGF is major stimulator in model of choroidal neovascularization.Invest Ophthalmol Vis Sci2000https://conductscience.org/library/papers/10967078PubMed

See all 30 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42599042The Role of Dopaminergic Agonists in Geographic Atrophy: Converging Evidence From Clinical and Experimental Data.Transl Vis Sci Technol2026https://conductscience.org/library/papers/42599042PubMed
42474422L-DOPA Promotes Post-Treatment Neurovascular and Synaptic Homeostasis in Early Diabetic Retinopathy.Invest Ophthalmol Vis Sci2026https://conductscience.org/library/papers/42474422PubMed
41757060L-DOPA treatment promotes sustained neurovascular and synaptic homeostasis in the diabetic retina.bioRxiv2026https://conductscience.org/library/papers/41757060PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41533907

GET https://conductscience.org/api/papers/v1/41533907/references?page=2